Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Reboot Rx uses AI to rapidly identify promising generic drugs for cancer treatment from thousands of published studies. The organization supports innovative funding models to close the gap in financing clinical trials needed to change standards of care. It collaborates widely across academia, healthcare systems, and industry stakeholders. Clinical results are not directly reported as it acts as an enabler rather than a direct sponsor of individual investigational new drug programs[1][2][3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Reboot Rx.